Yu-Lan Chen Li-Xiong Liu Qin Huang Xue-Ying Li Xiao-Ping Hong Dong-Zhou Liu
10.3389/fimmu.2021.654376
Front Immunol
2021 Apr 14;12:654376.
janus kinase inhibitor diffuse non-scarring alopecia hair regrowth systemic lupus erythematosus tofacitinib
CC BY
https://pubmed.ncbi.nlm.nih.gov/33936080/
Alopecia Areata / drug therapy Alopecia Areata / etiology Lupus Erythematosus, Systemic / complications Piperidines / therapeutic use Protein Kinase Inhibitors / therapeutic use Pyrimidines / therapeutic use
Alopecia Areata / drug therapy Alopecia Areata / etiology Lupus Erythematosus, Systemic / complications Piperidines / therapeutic use Protein Kinase Inhibitors / therapeutic use Pyrimidines / therapeutic use Case Reports Research Support, Non-U.S. Gov't Adult Alopecia Areata / diagnosis Chronic Disease Female Humans Lupus Erythematosus, Systemic / diagnosis Recurrence Treatment Outcome Piperidines Protein Kinase Inhibitors Pyrimidines tofacitinib
PMC8080875
33936080
Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
2021